Impact of primary care provider density on detection and diagnosis of cutaneous melanoma

PloS One
Nathaniel H FlemingEran Bendavid

Abstract

Early diagnosis of cutaneous melanoma is critical in preventing melanoma-associated deaths, but the role of primary care providers (PCPs) in diagnosing melanoma is underexplored. We aimed to explore the association of PCP density with melanoma incidence and mortality. All cases of cutaneous melanoma diagnosed in the United States from 2008-2012 and reported in the Surveillance, Epidemiology, and End Results (SEER) database were analyzed in 2016. County-level primary care physician density was obtained from the Area Health Resources File (AHRF). We conducted multivariate linear regression using 1) average annual melanoma incidence or 2) average annual melanoma mortality by county as primary outcomes, adjusting for demographic confounders and dermatologist density. Cox proportional hazard regression was conducted using individual outcome data from SEER with the same covariates. Across 611 counties, 167,305 cases of melanoma were analyzed. Per 100,000 people, an additional 10 PCPs per county was associated with 1.62 additional cases of melanoma per year (95% CI 1.06-2.18, p<0.001). This increased incidence occurred disproportionally in early-stage melanoma (Stage 0: 0.69 cases (0.38-1.00), p<0.001; Stage I: 0.63 cases (0.37-0.89),...Continue Reading

References

Mar 29, 2002·The Journal of Pathology·Lieve BrochezJean-Marie Naeyaert
Aug 6, 2005·BMJ : British Medical Journal·H Gilbert WelchLisa M Schwartz
Apr 19, 2006·Archives of Dermatology·Megan M MooreBarbara A Gilchrest
Jul 1, 2006·Journal of General Internal Medicine·Suephy C ChenWilliam S Weintraub
Jun 13, 2009·The British Journal of Dermatology·N J LevellD C Greenberg
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Apr 20, 2010·The American Journal of Medicine·Elliot J CoupsSharon L Manne
Apr 24, 2010·Journal of the National Cancer Institute·H Gilbert Welch, William C Black
Jul 27, 2010·Journal of General Internal Medicine·Ashwin N AnanthakrishnanKia Saeian
Nov 15, 2011·Journal of the American Academy of Dermatology·Eckhard W BreitbartAlexander Katalinic
Dec 14, 2011·Journal of the American Academy of Dermatology·Jason E FrangosAlexa B Kimball
Jan 4, 2012·Journal of Cutaneous Pathology·Wolfgang Weyers
Nov 10, 2013·Journal of the American Board of Family Medicine : JABFM·Richard G RoetzheimEllen P McCarthy
Nov 10, 2013·Journal of the American Board of Family Medicine : JABFM·Melody J EideUNKNOWN INFORMED (INternet course FOR Melanoma Early Detection) Group
Jul 1, 2014·Journal of the American Academy of Dermatology·Matthew J LinJohn W Kelly
Dec 3, 2014·American Journal of Preventive Medicine·Gery P GuyK Robin Yabroff
Feb 25, 2015·Current Medical Research and Opinion·Xue SongMarilyn Novich
Sep 17, 2015·BMJ Open·Mathieu BoniolSara Gandini
Jul 9, 2016·Cancer·Clara Curiel-Lewandrowski, Susan M Swetter
Jul 28, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceAlbert L Siu
Feb 28, 2017·JAMA Oncology·Laura K FerrisJohn M Kirkwood
Jun 9, 2017·JAMA Dermatology·Susan M SwetterSteven M Asch

❮ Previous
Next ❯

Citations

May 14, 2020·Melanoma Management·Rachael MillerEmilie Scherrer
Dec 17, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·L Kandolf-SekulovicC Garbe
Aug 14, 2020·Journal of the American Academy of Dermatology·Jose L CortezMaria L Wei
Jun 6, 2021·Semergen·R Chenlo BarrosA Clavería Fontán

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy

Software Mentioned

Stata
SEER

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.